| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
18 |
| Employees |
8 |
| Revenues (TTM) (Millions $) |
1 |
| Net Income (TTM) (Millions $) |
-7 |
| Cash Flow (TTM) (Millions $) |
-1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Harvard Apparatus Regenerative Technology Inc (HART) is a biotechnology company focused on developing regenerative medicine products for tissue engineering and cell therapy applications. The company's goal is to advance the field of regenerative medicine by creating innovative solutions that can repair or replace damaged tissues and organs.
HART has expertise in bioengineering, stem cell biology, and tissue engineering, which enables them to develop and commercialize novel products. They have developed a range of advanced technologies, including 3D bioprinting, tissue scaffolds, and cell culture systems, that facilitate the growth and differentiation of cells for therapeutic purposes.
The company's products are designed to address various medical conditions, such as chronic wounds, organ failure, and degenerative diseases. They aim to improve patient outcomes and quality of life by providing innovative treatments that can potentially restore normal tissue function.
HART collaborates with academic institutions, research organizations, and industry partners to advance their research and development efforts. They also work closely with regulatory agencies to ensure compliance with safety and efficacy standards.
In summary, Harvard Apparatus Regenerative Technology Inc is a biotechnology company that specializes in developing regenerative medicine products to repair and replace damaged tissues and organs. They aim to revolutionize the field of regenerative medicine by offering innovative solutions to treat various medical conditions.
Company Address: 84 October Hill Road, Suite 11 Holliston 1746 MA
Company Phone Number: 233-7300 Stock Exchange / Ticker: BSTG
|
%
26.51% 
283.19 %